Organization
Rush University Medical Center, Chicago, IL
6 abstracts
Abstract
Health-related quality of life (HRQoL) results for adjuvant alectinib vs chemotherapy in patients with resected ALK+ non-small cell lung cancer (NSCLC): Data from ALINA.Org: Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China, Gustave Roussy and Paris Saclay University, Faculty of Medicine, Villejuif / Kremlin-Bicêtre, France, Samsung Medical Center, Seoul, South Korea, Asan Medical Center, Seoul, South Korea,
Abstract
NRG Oncology/RTOG 0848: Results after adjuvant chemotherapy +/- chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA).Org: Rush University Medical Center, NRG Oncology SDMC/ACR, Mount Sinai Medical Center, University of Maryland, Baltimore, MD, Brown University School of Medicine-Rhode Island Hospital,
Abstract
A randomized, double-blind, placebo-controlled phase II study of adjuvant pembrolizumab versus placebo in patients with head and neck squamous cell cancers at high risk for recurrence: The PATHWay study.Org: Department of Medicine, University of Chicago, Johns Hopkins Medicine, University of Pennsylvania, Emory University Winship Cancer Institute, Hollings Cancer Center,
Abstract
RNA sequencing to characterize pathways in EGFR-mutated non-small cell lung cancer.Org: Rush University Medical Center, Chicago, IL,
Abstract
A RAPID3-LIKE INDEX DOCUMENTS SUPERIOR EFFICACY OF BARICITINIB TO ADALIMUMAB AND PLACEBO, SIMILAR TO DAS28 AND CDAI IN THE RA-BEAM CLINICAL TRIAL IN PATIENTS WITH RHEUMATOID ARTHRITIS Org: Rush University Medical Center, Chicago, IL, Eli Lilly and Company, Indianapolis, United States,
Abstract
ADALIMUMAB IN NON-INFECTIOUS UVEITIS – EFFICACY ACROSS DIFFERENT ETIOLOGIES IN THE VISUAL I AND VISUAL II TRIALS Org: Rush University Medical Center, Chicago, IL, University of Utah, Salt Lake City, United States, University of Tuebingen, Center of Ophthalmology, Tuebingen, Germany, University of Montreal, Montreal, Canada, Tokyo Medical University, Tokyo, Japan,